000 01516 a2200361 4500
005 20250517003859.0
264 0 _c20151209
008 201512s 0 0 eng d
022 _a1556-1380
024 7 _a10.1097/JTO.0000000000000350
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAwad, Mark M
245 0 0 _aSuccessful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinib.
_h[electronic resource]
260 _bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
_cNov 2014
300 _a1726-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aCrizotinib
650 0 4 _aDrug Hypersensitivity
_xetiology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aPyrazoles
_xadministration & dosage
650 0 4 _aPyridines
_xadministration & dosage
700 1 _aLax, Timothy P
700 1 _aSlawski, Benjamin R
700 1 _aShaw, Alice T
773 0 _tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
_gvol. 9
_gno. 11
_gp. 1726-8
856 4 0 _uhttps://doi.org/10.1097/JTO.0000000000000350
_zAvailable from publisher's website
999 _c24391914
_d24391914